Title |
Does HPV type affect outcome in oropharyngeal cancer?
|
---|---|
Published in |
Journal of Otolaryngology - Head & Neck Surgery, February 2013
|
DOI | 10.1186/1916-0216-42-9 |
Pubmed ID | |
Authors |
Anthony C Nichols, Sandeep S Dhaliwal, David A Palma, John Basmaji, Corina Chapeskie, Samuel Dowthwaite, Jason H Franklin, Kevin Fung, Keith Kwan, Brett Wehrli, Chris Howlett, Iram Siddiqui, Marina I Salvadori, Eric Winquist, Scott Ernst, Sara Kuruvilla, Nancy Read, Varagur Venkatesan, Biljana Todorovic, J Alex Hammond, James Koropatnick, Joe S Mymryk, John Yoo, John W Barrett |
Abstract |
An epidemic of human papillomavirus (HPV)-related oropharyngeal squamous cell cancer (OPSCC) has been reported worldwide largely due to oral infection with HPV type-16, which is responsible for approximately 90% of HPV-positive cases. The purpose of this study was to determine the rate of HPV-positive oropharyngeal cancer in Southwestern Ontario, Canada. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 1% |
United States | 1 | 1% |
Russia | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 63 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 27% |
Researcher | 8 | 12% |
Student > Ph. D. Student | 6 | 9% |
Professor | 6 | 9% |
Student > Bachelor | 6 | 9% |
Other | 14 | 21% |
Unknown | 9 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 57% |
Biochemistry, Genetics and Molecular Biology | 6 | 9% |
Agricultural and Biological Sciences | 5 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 1% |
Economics, Econometrics and Finance | 1 | 1% |
Other | 3 | 4% |
Unknown | 13 | 19% |